Microbiome Connect: USA 2022

Microbiome Connect: Where innovation meets industry

Clinically validating novel mechanisms of action, accelerating rational drug development strategies, and establishing commercial ready manufacturing platforms

DOWNLOAD THE 2022 AGENDA
BOSTON, USA
16-17 November, 2022

“This event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science. Kisaco has gone out of their way to include speakers and perspectives not found elsewhere. I look forward to attending again.”

KC Microbiome Communications Group

Why Attend

The 7th annual Microbiome Connect: USA is dedicated to showcasing the leading drug development platforms applying microbes, microbe modulators and microbial-derived components to prevent or treat human diseases or make medical diagnosis.

As the first FDA approved microbiome-targeted therapeutic emerges, drug developers will have the opportunity to benchmark their rational drug platforms, targeting validated pathways in gastrointestinal, neurological, metabolic disorders, as well as oncology-based indications.

Furthermore, the manufacturing challenges associated with reaching commercialisation specific to microbiome-based drugs will be addressed in depth. With talks from Live Biotherapeutic Product manufacturing experts, including the Head of CBER, on topics including how to handle USP 61/62, and achieving co-culturing capabilities.

Join us to hear from microbiome biotechs, pharma voices, investment bodies, and more on how to develop robust, scalable, and reproducible formulations for microbe-derived/-targeting products entering late-stage investigations and reaching for the market.

200+
Attendees
50+
Leading Top Speakers
10+
Hours of Dedicated Networking

AUDIENCE BREAKDOWN

40%
Biotechs
20%
Pharma & Investors
30%
Academia
10%
Service Providers

Biotechs

Pharma & Investors

Academia

Service Providers

DISCOVER THE TRACKS

Track 1: Emerging Therapeutic Areas & Pipeline Updates -

sponsored by:

Designed for R&D experts to discuss the latest data from gastro- and extra-intestinal indications

Track 2: Advanced Bioprocessing Strategies for LBPs & Microbiome Therapeutics - sponsored by:

Designed for manufacturing leaders to share insights on the latest logistical and bioprocessing barriers

Standards For Microbiome Measurement

On November 15, we will be hosting a pre-event workshop in partnership with NIST (National Institute of Standards and Technology) and MTIG (Microbiome Therapeutics Innovation Group).

Click below to register your interest in attending this exclusive learning experience:

REGISTER YOUR INTEREST

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Preparing registration...

Biotech Showcase: attract investment to your pipeline

Are you looking to attract investment to your pipeline?

The Biotech Showcase provides microbiome companies with unique and interesting pipelines the opportunity to present their data in front of our audience of investors and industry leaders.

Designed to showcase the innovative work taking place in the microbiome industry.

Submit your application below. This will be reviewed by the Microbiome Connect Team, who will be in touch.

Deadline for applications is October 21st 2022.

If you have any questions please contact [email protected].

SUBMIT NOW

FOUNDERS FORUM: CONNECT WITH INDUSTRY PEERS

Are you looking to grow your business network? 

Join CEOs, Founders and Business Leaders to collaborate, brainstorm ideas, share pain-points and find solutions to the current challenges of launching and running a successful microbiome biotech today.

Get straight to the heart of the issues at the top of your priority list with other biotech leaders

Register below, and a member of the Microbiome Connect Team will be in touch.

If you have any questions please contact [email protected].

REGISTER NOW 

2022 SPEAKER FACULTY

 

Peter Marks

Director
Center for Biologics Evaluation and Research, FDA

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development.  He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Peter Marks

Director
Center for Biologics Evaluation and Research, FDA

Peter Marks

Director
Center for Biologics Evaluation and Research, FDA

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development.  He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

 

Vanessa Ridaura

Senior Program Officer
Microbiome Products at Bill & Melinda Gates Foundation

Vanessa Ridaura

Senior Program Officer
Microbiome Products at Bill & Melinda Gates Foundation

Vanessa Ridaura

Senior Program Officer
Microbiome Products at Bill & Melinda Gates Foundation
 

Thomas Gurry

CEO
Myota

Thomas Gurry

CEO
Myota

Thomas Gurry

CEO
Myota
 

Nini Fan

CEO
Mamome

Nini Fan

CEO
Mamome

Nini Fan

CEO
Mamome
 

Vivek Lal

CEO
Alveolus Bio

Vivek Lal

CEO
Alveolus Bio

Vivek Lal

CEO
Alveolus Bio
 

Benjamin Hadida

CEO
Exeliom

Benjamin Hadida

CEO
Exeliom

Benjamin Hadida

CEO
Exeliom
 

Sandrine Miller-Montgomery

CEO
Micronoma

Sandrine Miller-Montgomery

CEO
Micronoma

Sandrine Miller-Montgomery

CEO
Micronoma
 

Stewart Campbell

CEO
Axial Biotherapeutics

Dr. Campbell joined Axial in 2016 as Vice President of Research & Development, and was appointed the company’s CEO in February 2021. in 27+ years in the pharma/biotech industry, Dr. Campbell held various leadership roles at Boehringer-Ingelheim, Insmed, Surface Logix, Ancora/Corden Pharma and Axial, Dr. Campbell has played an integral role in the discovery and development of eight clinical stage drug candidates, including the Rho kinase inhibitor belumosudil and TAK-607 (rIGF-1/BP-3). During his career Dr. Campbell has been co-inventor on 20 issued patents.

Stewart Campbell

CEO
Axial Biotherapeutics

Stewart Campbell

CEO
Axial Biotherapeutics

Dr. Campbell joined Axial in 2016 as Vice President of Research & Development, and was appointed the company’s CEO in February 2021. in 27+ years in the pharma/biotech industry, Dr. Campbell held various leadership roles at Boehringer-Ingelheim, Insmed, Surface Logix, Ancora/Corden Pharma and Axial, Dr. Campbell has played an integral role in the discovery and development of eight clinical stage drug candidates, including the Rho kinase inhibitor belumosudil and TAK-607 (rIGF-1/BP-3). During his career Dr. Campbell has been co-inventor on 20 issued patents. He holds a BSc with Honors in Chemistry from St. Francis Xavier University, a Ph.D. in Organic Chemistry from the Queen’s University (Canada), and did post-doctoral research at Duke University.

 

 

 

Shrish Budree

Senior Medical Director
Finch Therapeutics

Shrish Budree

Senior Medical Director
Finch Therapeutics

Shrish Budree

Senior Medical Director
Finch Therapeutics
 

Koji Yasuda

Associate Director
Pfizer

Koji Yasuda

Associate Director
Pfizer

Koji Yasuda

Associate Director
Pfizer
 

Todd Krueger

President & CEO
AOBiome

Todd Krueger

President & CEO
AOBiome

Todd Krueger

President & CEO
AOBiome
 

Leigh A. Frame, PHD, MHS

Associate Director, Resiliency & Well-being Center, Program Director
Integrative Medicine

Leigh A. Frame, PHD, MHS

Associate Director, Resiliency & Well-being Center, Program Director
Integrative Medicine

Leigh A. Frame, PHD, MHS

Associate Director, Resiliency & Well-being Center, Program Director
Integrative Medicine
 

Scott Jackson

leader, Complex Microbial Systems
National institute of Standards and Technology

Scott Jackson

leader, Complex Microbial Systems
National institute of Standards and Technology

Scott Jackson

leader, Complex Microbial Systems
National institute of Standards and Technology
 

Paul Carlson

Principal Investigator
FDA

Paul Carlson

Principal Investigator
FDA

Paul Carlson

Principal Investigator
FDA
 

Sabine Hazan

Chief Executive Officer
ProgenaBiome

Sabine Hazan

Chief Executive Officer
ProgenaBiome

Sabine Hazan

Chief Executive Officer
ProgenaBiome
 

Dr Elran Haber

CEO
Biomica

Dr Elran Haber

CEO
Biomica

Dr Elran Haber

CEO
Biomica
 

Fabio Grassi

Chairman
MVBiotherapeutics

Fabio Grassi

Chairman
MVBiotherapeutics

Fabio Grassi

Chairman
MVBiotherapeutics
 

Sou Miyake

Director of Business Development
Corundum Systems Biology

Sou Miyake

Director of Business Development
Corundum Systems Biology

Sou Miyake

Director of Business Development
Corundum Systems Biology
 

Georg Gerber K.,M.,D.,Ph.D.,M.P.H.,

Assistant Professor
Harvard

Georg Gerber K.,M.,D.,Ph.D.,M.P.H.,

Assistant Professor
Harvard

Georg Gerber K.,M.,D.,Ph.D.,M.P.H.,

Assistant Professor
Harvard
 

Katie Leitch

VP Manufacturing Sciences and Technology
Seres Therapeutics

Katie Leitch

VP Manufacturing Sciences and Technology
Seres Therapeutics

Katie Leitch

VP Manufacturing Sciences and Technology
Seres Therapeutics
 

Bharat Dixit

Chief Technology Officer
Adiso Therapeutics

Bharat Dixit

Chief Technology Officer
Adiso Therapeutics

Bharat Dixit

Chief Technology Officer
Adiso Therapeutics
 

Denise Kelly

Partner
Seventure Partners

Denise Kelly

Partner
Seventure Partners

Denise Kelly

Partner
Seventure Partners
 

Naveen Krishnan

Senior Director of Venture Investment
Leaps by Bayer

Naveen Krishnan

Senior Director of Venture Investment
Leaps by Bayer

Naveen Krishnan

Senior Director of Venture Investment
Leaps by Bayer
 

Diwikar Davar

Associate Director
Pfizer

Diwikar Davar

Associate Director
Pfizer

Diwikar Davar

Associate Director
Pfizer
 

Romain Daillere

Co-founder
Everimmune

Romain Daillere

Co-founder
Everimmune

Romain Daillere

Co-founder
Everimmune
 

Larry Weiss

CEO
Symbiome

Larry Weiss

CEO
Symbiome

Larry Weiss

CEO
Symbiome
 

Cheri Ackerman

CEO
Concerto Biosciences

Cheri Ackerman

CEO
Concerto Biosciences

Cheri Ackerman

CEO
Concerto Biosciences
 

Trevor Steyn

CEO
ESSE

Trevor Steyn

CEO
ESSE

Trevor Steyn

CEO
ESSE
 

Dan Couto

COO
Vedanta

Dan Couto

COO
Vedanta

Dan Couto

COO
Vedanta
 

Ron Shmueli

Senior Formulation Scientist
Synlogic

Ron Shmueli

Senior Formulation Scientist
Synlogic

Ron Shmueli

Senior Formulation Scientist
Synlogic
 

Nikhil Sharma

CEO
BioCoreTex

Nikhil Sharma

CEO
BioCoreTex

Nikhil Sharma

CEO
BioCoreTex
 

Chris Ford

VP Translational Biology
Seres Therapeutics

Chris Ford

VP Translational Biology
Seres Therapeutics

Chris Ford

VP Translational Biology
Seres Therapeutics
 

Anik Debanth

CEO
Tenza Bio

Anik Debanth

CEO
Tenza Bio

Anik Debanth

CEO
Tenza Bio
 

Johan E.T. van Hylckama Vlieg

CSO and Co-founder
Clinical Stage Microbial Immunotherapy Company

Johan E.T. van Hylckama Vlieg

CSO and Co-founder
Clinical Stage Microbial Immunotherapy Company

Johan E.T. van Hylckama Vlieg

CSO and Co-founder
Clinical Stage Microbial Immunotherapy Company
 

Peter Lee MD

CEO
Osel

Peter Lee MD

CEO
Osel

Peter Lee MD

CEO
Osel
 

Marina Santiago

Director of R&D
Fitbiomics

Marina Santiago

Director of R&D
Fitbiomics

Marina Santiago

Director of R&D
Fitbiomics
 

Sheng-Lin Gibson

Chief of the Biosystems and Biomaterials Division
National Institute of Standards and Technology

Sheng-Lin Gibson

Chief of the Biosystems and Biomaterials Division
National Institute of Standards and Technology

Sheng-Lin Gibson

Chief of the Biosystems and Biomaterials Division
National Institute of Standards and Technology
 

Staffan Stromberg

Chief Executive Officer
Infant Bacterial Therapeutics

Staffan Stromberg

Chief Executive Officer
Infant Bacterial Therapeutics

Staffan Stromberg

Chief Executive Officer
Infant Bacterial Therapeutics
 

Zack Abbott

Chief Executive Officer
Z-Biotics

Zack Abbott

Chief Executive Officer
Z-Biotics

Zack Abbott

Chief Executive Officer
Z-Biotics
 

Jason Norman

Senior Director of Systems Biology
Vedanta Biosciences

Jason Norman

Senior Director of Systems Biology
Vedanta Biosciences

Jason Norman

Senior Director of Systems Biology
Vedanta Biosciences
 

Nikole Kimes

Founder & Chief Executive Officer
Siolta Therapeutics

Nikole Kimes

Founder & Chief Executive Officer
Siolta Therapeutics

Nikole Kimes

Founder & Chief Executive Officer
Siolta Therapeutics
 

Felix Faupel

Chief Commercial Officer
Bacthera

Felix Faupel

Chief Commercial Officer
Bacthera

Felix Faupel

Chief Commercial Officer
Bacthera
 

Stacy Burns Gurdish

President
List Labs

Stacy Burns Gurdish

President
List Labs

Stacy Burns Gurdish

President
List Labs
 

Joe Trebley

Chief Executive Officer
Scioto Biosciences, Inc

Joe Trebley

Chief Executive Officer
Scioto Biosciences, Inc

Joe Trebley

Chief Executive Officer
Scioto Biosciences, Inc
 

Tomas de Wouters

CEO
PharmaBiome

Tomas de Wouters

CEO
PharmaBiome

Tomas de Wouters

CEO
PharmaBiome
 

Manoj Dadlani

Chief Executive Officer
CosmosID

Manoj Dadlani

Chief Executive Officer
CosmosID

Manoj Dadlani

Chief Executive Officer
CosmosID
 

Mary Poor

Vice President of Quality and CMC
Siolta Therapeutics

Mary Poor

Vice President of Quality and CMC
Siolta Therapeutics

Mary Poor

Vice President of Quality and CMC
Siolta Therapeutics
 

Tonya Ward

Senior Director of Bioinformatics & Laboratory Operations
Diversigen

Tonya Ward

Senior Director of Bioinformatics & Laboratory Operations
Diversigen

Tonya Ward

Senior Director of Bioinformatics & Laboratory Operations
Diversigen
 

Kit Goldman

Senior Director, Dietary Supplements and Herbal Medicines
US Pharmacopeia

Kit Goldman

Senior Director, Dietary Supplements and Herbal Medicines
US Pharmacopeia

Kit Goldman

Senior Director, Dietary Supplements and Herbal Medicines
US Pharmacopeia
 

Ryan Wilson

Head of Microbiome Programs
Quay Pharmaceuticals

Ryan Wilson

Head of Microbiome Programs
Quay Pharmaceuticals

Ryan Wilson

Head of Microbiome Programs
Quay Pharmaceuticals
 

Nicolas Pichon

Head of Bioprocessing & Production
Servatus

Nicolas Pichon

Head of Bioprocessing & Production
Servatus

Nicolas Pichon

Head of Bioprocessing & Production
Servatus

2022 ATTENDEES

Testimonials

Microbiome Connect Gut Therapeutics Boston 2021 Kisaco Research

OUR 2022 SPONSORS

Headline Partner

Platinum Partner

Gold Partners

Silver Partner

Event Partner

Associate Media Partner

Resources

Download Resource

Venue

The Westin Boston Seaport District 425 Summer Street, Boston, MA, 02210

To view hotels nearby with a discounted rate, please click here: https://HotelMap.com/MRG6U

Partner With Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected]

DOWNLOAD SPEX PROSPECTUS

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us